News

BIOC

Seattle Genetics to Acquire Cascadian Therapeutics

Edward Kim | Equities.com |

SGEN adds CASC's late stage breast cancer therapeutic pipeline.


Biocept (BIOC): bringing a Cost-Efficient and more Accurate Liquid Biopsy to the Market

Stephen L Kanaval | Equities.com |

Biocept Inc. (BIOC) has patented molecular diagnostic technology that uses an antibody to detect circulating tumor cells (CTCs)


Biocept at the Forefront of Liquid Biopsy

Stephen L Kanaval | Equities.com |

Many tissue biopsies for lung cancer don’t give doctors the answers they need. Biocept's liquid biopsy technology could change all of that.


12 IPOs Planned for February 3 Week

Francis Gaskins | Equities.com |

The full IPO calendar is available at IPOpremium.com Ranked by size of IPO, largest first. (1) Real estate finance Based in New York, NY, Ladder Capital ($LADR) scheduled a $225 million IPO on the


IPO Report: Biocept (BIOC)

Francis Gaskins | Equities.com |

Biocept (BIOC) is an early-stage cancer diagnostics company that develops and commercializes proprietary circulating tumor cell, or CTC, and circulating tumor DNA, or ctDNA, tests utilizing a


Stocks Under $10: Medical Products & Services

Richard Suttmeier | Equities.com |

At www.ValuEngine.com we show that the Medical sector is 9.8% overvalued. The Medical Products industry is 4.2% overvalued. The Medical Services industry is 9.1% overvalued. The Medical


Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     

Blockchain in Mobility - Discussion at the EU Parliament

From the recent Blockchain For Europe Summit in Brussels: Panel on Mobility and Transportation